These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 25870932)

  • 1. Hyaluronic Acid Filler in HIV-Associated Facial Lipoatrophy: Evaluation of Tissue Distribution and Morphology with MRI.
    Becker M; Balagué N; Montet X; Calmy A; Salomon D; Toutous-Trellu L;
    Dermatology; 2015; 230(4):367-74. PubMed ID: 25870932
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Patient Reported Outcomes from HIV Facial Lipoatrophy Treatment With a Volumizing Hyaluronic Acid Filler: A Prospective, Open-Label, Phase I and II Study.
    Ho D; Jagdeo J
    J Drugs Dermatol; 2016 Sep; 15(9):1064-9. PubMed ID: 27602967
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy and durability of hyaluronic acid fillers for malar enhancement: A prospective, randomized, split-face clinical controlled trial.
    Jeong KH; Gwak MJ; Moon SK; Lee SJ; Shin MK
    J Cosmet Laser Ther; 2018 Jun; 20(3):184-188. PubMed ID: 28135883
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Safety and Efficacy of a Volumizing Hyaluronic Acid Filler for Treatment of HIV-Associated Facial Lipoatrophy.
    Ho D; Jagdeo J
    JAMA Dermatol; 2017 Jan; 153(1):61-65. PubMed ID: 27806168
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Changes in facial fat in HIV-related lipoatrophy, wasting, and weight gain measured by magnetic resonance imaging.
    Paton NI; Yang Y; Tha NO; Sitoh YY
    HIV Clin Trials; 2007; 8(4):227-34. PubMed ID: 17720663
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cerebral Angiographic Findings of Cosmetic Facial Filler-related Ophthalmic and Retinal Artery Occlusion.
    Kim YK; Jung C; Woo SJ; Park KH
    J Korean Med Sci; 2015 Dec; 30(12):1847-55. PubMed ID: 26713062
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Temporal fossa defects: techniques for injecting hyaluronic acid filler and complications after hyaluronic acid filler injection.
    Juhász ML; Marmur ES
    J Cosmet Dermatol; 2015 Sep; 14(3):254-9. PubMed ID: 26311237
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The reconstructed skin model as a new tool for investigating in vitro dermal fillers: increased fibroblast activity by hyaluronic acid.
    Girardeau-Hubert S; Teluob S; Pageon H; Asselineau D
    Eur J Dermatol; 2015; 25(4):312-22. PubMed ID: 26065380
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A comparison of lipoatrophy and aging: volume deficits in the face.
    Coleman S; Saboeiro A; Sengelmann R
    Aesthetic Plast Surg; 2009 Jan; 33(1):14-21. PubMed ID: 18987910
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-Term Correction of Iatrogenic Lipoatrophy With Volumizing Hyaluronic Acid Filler.
    Hausauer AK; Jones DH
    Dermatol Surg; 2018 Nov; 44 Suppl 1():S60-S62. PubMed ID: 30359336
    [No Abstract]   [Full Text] [Related]  

  • 11. Facial fat volume in HIV-infected patients with lipoatrophy.
    Yang Y; Sitoh YY; Oo Tha N; Paton NI
    Antivir Ther; 2005; 10(4):575-81. PubMed ID: 16038484
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High-density hyaluronic acid for the treatment of HIV-related facial lipoatrophy.
    Pignatti M; Pedone A; Baccarani A; Guaraldi G; Orlando G; Lombardi M; De Santis G
    Aesthetic Plast Surg; 2012 Feb; 36(1):180-5. PubMed ID: 21717261
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of the In Vivo Kinetics and Biostimulatory Effects of Subcutaneously Injected Hyaluronic Acid Filler.
    Mochizuki M; Aoi N; Gonda K; Hirabayashi S; Komuro Y
    Plast Reconstr Surg; 2018 Jul; 142(1):112-121. PubMed ID: 29952893
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Polylactic acid injections: usefullness for the treatment of facial lipoatrophy in HIV+ patients under tritherapy].
    Piquet M; Brignol L; Chatelain B; Rey D; Ricbourg B; Meyer C
    Rev Stomatol Chir Maxillofac; 2007 Dec; 108(6):496-504. PubMed ID: 17675198
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anatomic location of hyaluronic acid filler material injected into nasolabial fold: a histologic study.
    Arlette JP; Trotter MJ
    Dermatol Surg; 2008 Jun; 34 Suppl 1():S56-62; discussion S62-3. PubMed ID: 18547183
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Use of hyaluronic acid for soft tissue augmentation of HIV-associated facial lipodystrophy.
    Gooderham M; Solish N
    Dermatol Surg; 2005 Jan; 31(1):104-8. PubMed ID: 15720106
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hyaluronic Acid After Subcutaneous Injection-An Objective Assessment.
    Santer V; Molliard SG; Micheels P; Río-Sancho SD; Quinodoz P; Kalia YN; Salomon D
    Dermatol Surg; 2019 Jan; 45(1):108-116. PubMed ID: 29994953
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Voluma: A Systematic Review of Clinical Experience.
    Ho D; Jagdeo J
    J Drugs Dermatol; 2015 Sep; 14(9):934-40. PubMed ID: 26355610
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tracking and Increasing Viability of Topically Injected Fibroblasts Suspended in Hyaluronic Acid Filler.
    You HJ; Namgoong S; Rhee SM; Han SK
    J Craniofac Surg; 2016 Mar; 27(2):521-5. PubMed ID: 26854786
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Soft tissue distribution pattern of facial soft tissue fillers with different viscoelastic properties.
    Rosamilia G; Hamade H; Freytag DL; Frank K; Green JB; Devineni A; Gavril DL; Hernandez CA; Pavicic T; Cotofana S
    J Cosmet Dermatol; 2020 Feb; 19(2):312-320. PubMed ID: 31922337
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.